STREAMEX CORP.

STEX ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2024 FY2023 FY2022 FY2021 FY2020
Revenue $40.0K $18.0K $286.0K $441.0K $0
Cost of Revenue $57.0K $199.0K $0
Gross Profit $18.0K $229.0K $242.0K $0
Gross Margin 100.0% 80.1% 54.9%
Operating Expenses
Research & Development $832.0K $5.1M $5.8M $5.6M $18.1M
SG&A Expense $11.6M $23.1M $21.4M $27.9M $41.0M
Operating Income $-12.9M $-28.5M $-27.3M $-33.4M $-59.2M
Operating Margin -32,155.0% -158,400.0% -9,533.2% -7,576.2%
Interest Expense
Pretax Income $-10.3M $-28.7M $-27.3M $-32.9M $-59.1M
Income Tax Expense $0 $0 $0
Net Income $-10.3M $-29.0M $-27.1M $-31.9M $-52.2M
Net Margin -25,825.0% -161,338.9% -9,458.7% -7,237.4%
EPS (Basic) $-0.25 $-1.32 $-2.11 $-0.62
EPS (Diluted) $-0.25 $-1.32 $-2.11 $-0.62
Shares Outstanding (Basic) 42.1M 22.1M 12.9M 106.7M 92.3M
Shares Outstanding (Diluted) 42.1M 22.1M 12.9M 106.7M 92.3M
Dividends Per Share